Stifel Nicolaus reaffirmed their buy rating on shares of Krystal Biotech (NASDAQ:KRYS – Free Report) in a research report released on Tuesday, Benzinga reports. They currently have a $204.00 price target on the stock, up from their prior price target of $178.00. Other research analysts have also recently issued reports about the stock. William Blair […]
Krystal Biotech, Inc (NASDAQ:KRYS) Receives $157 67 Average Target Price from Brokerages theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
China Universal Asset Management Co. Ltd. lifted its position in Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) by 353.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,259 shares of the company’s stock after buying an additional 2,541 shares during the […]
Q1 2024 EPS Estimates for Krystal Biotech, Inc (NASDAQ:KRYS) Boosted by William Blair theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Krystal Biotech (NASDAQ:KRYS – Get Free Report) posted its quarterly earnings data on Monday. The company reported $0.30 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.52) by $0.82, MarketWatch Earnings reports. The company had revenue of $42.14 million for the quarter, compared to analysts’ expectations of $27.43 million. During the same […]